Pharma News

Bristol-Myers Squibb and Syngene International Extend Research Collaboration

  • Posted on: 3 June 2014
  • By: PharmaTutor News

(Business Wire India; 3rd June, 2014); Bristol-Myers Squibb and Syngene International, India’s largest contract research organization, today announced a five-year extension of their drug discovery and development collaboration in India. Financial terms were not disclosed.
Since 2007, Bristol-Myers Squibb has been working with Syngene and its corporate parent, Biocon Ltd., to develop integrated capabilities in medicinal and process chemistry, biology, biotechnology, biomarkers, drug metabolism and pharmacokinetics, analytical research, and pharmaceutical development at the Biocon Bristol-Myers Squibb Research Center (BBRC) in Bangalore.

Free drug policy to be streamlined for integration with NHM

(1st June, 2014); Dr Harsh Vardhan, Union Minister for Health and Family Welfare, has asked for thorough streamlining of systems in the distribution of free generic drugs to government health institutions at all levels throughout the country. The Free Drug Programme’s formal launch would be preceded by working out all logistical details with respect to procurement and distribution in consultation with the state governments.

FDA approved blood test to determine non-ABO RBC types as transfusion medicine

  • Posted on: 22 May 2014
  • By: admin

(22nd May, 2014);The U.S. Food and Drug Administration (FDA) approved the Immucor PreciseType Human Erythrocyte Antigen (HEA) Molecular BeadChip Test (BeadChip Test), manufactured by BioArray Solutions Ltd. of Warren, New Jersey, the first FDA-approved molecular assay used in transfusion medicine to assist in determining blood compatibility. The assay can be used to determine donor and patient non-ABO/non-RhD (non-ABO) red blood cell (RBC) types in the United States.

Takeda Pharmaceuticals Partners with Wipro to Enable a Global “as-a-service” IT Platform

  • Posted on: 20 May 2014
  • By: PharmaTutor News

(Business Wire India; 20th May, 2014); Wipro Ltd., a leading global Information Technology, Consulting and Outsourcing company today announced a strategic partnership with Takeda Pharmaceutical Company Ltd., the largest pharmaceutical company in Japan and one of the global leaders of the industry.

Ferring launches Guts4life, An Interactive Online Resource for People with Inflammatory Bowel Disease

  • Posted on: 20 May 2014
  • By: PharmaTutor News

(Business Wire India; 19th May, 2014); Ferring Pharmaceuticals marks World IBD Day (May 19th) with the launch of Guts4life (guts4life.com), a new interactive website with information, support and inspiration for people concerned with Crohn’s disease and ulcerative colitis, conditions known as inflammatory bowel diseases (IBD). IBD describes a range of chronic diseases of the gastrointestinal system characterised by intermittent flares with debilitating symptoms that can affect a patient’s quality of life and lead to emotional distress and social isolation. Guts4life was designed together with IBD patients to provide support and encouragement throughout the IBD journey—from bowel symptom worries, to diagnosis, through managing and living with IBD.

Chemicals from toothpaste, sunscreen, toys, plastic bottles changes Swimming, Navigation and Penetration behaviour of Sperm

  • Posted on: 15 May 2014
  • By: PharmaTutor News

(15th May, 2014); Researchers from Center of Advanced European Studies and the University Department of Growth and Reproduction find out large amount of endocrine-disrupting chemicals interfere with human sperm function and that may have a negative impact on fertilization. The study indicates that the chemicals might evoke changes in swimming behaviour at the wrong time and wrong place, hinder navigation of sperm towards the egg and hamper penetration into the protective egg coat.

Jubilant Biosys and Orion Corporation Announces Unique Collaborative Discovery Program in Pain Management Area

(Business Wire India; 13th May, 2014); Jubilant Biosys, a Bengaluru-based subsidiary of Jubilant Life Sciences, and Orion Corporation (Orion), the largest pharmaceutical company in Finland, today announced a path breaking drug discovery collaboration to discover small molecule inhibitors in neuroscience therapeutic area. The research deal is aimed at developing drug that can benefit large population of people with unmet needs in the pain management area.

Pages